ONCAlert | 2017 San Antonio Breast Cancer Symposium

The Role of Lenvatinib in NSCLC Treatment

Lars Bastholt, MD
Published Online: 11:32 AM, Wed October 19, 2016

Lars Bastholt, MD, clinical oncologist, Odense University Hospital, discusses the role of lenvatinib in treating patients with non-small cell lung cancer (NSCLC).

Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.